Survivin expression predicts poor outcome in malignant lymphoma.

被引：0
|
作者：
Depowski, PL [1 ]
Graber, MW [1 ]
Purdy, S [1 ]
Ross, JS [1 ]
Nazeer, T [1 ]
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
941
引用
收藏
页码：161A / 161A
页数：1
相关论文
共 50 条
  • [1] Survivin expression predicts poor outcome in malignant lymphoma.
    Depowski, PL
    Graber, MW
    Purdy, S
    Ross, JS
    Nazeer, T
    MODERN PATHOLOGY, 2001, 14 (01) : 161A - 161A
  • [2] Nuclear survivin expression predicts poor outcome in cholangiocarcinoma
    Javle, MM
    Tan, DF
    Yu, JH
    LeVea, CM
    Li, FZ
    Kuvshinoff, BW
    Gibbs, JF
    HEPATO-GASTROENTEROLOGY, 2004, 51 (60) : 1653 - 1657
  • [3] Maintenance therapy in poor risk malignant lymphoma.
    Avilés, A
    Victoria, W
    Diaz-Maqueo, JC
    García, EL
    Talavera, A
    BLOOD, 1999, 94 (10) : 257B - 257B
  • [4] Survivin protein expression predicts poor outcome in patients with primary breast cancer.
    Ryan, B
    Konecny, G
    Kahlert, S
    Wang, H
    Crown, J
    Untch, M
    Pegram, M
    Slamon, DJ
    Duffy, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 15S - 15S
  • [5] Expression of CARD signal transduction adapters in malignant lymphoma.
    Mahwech, P
    Ho, LZ
    Bertin, J
    Gindre, P
    Schwaller, J
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 643 - 643
  • [6] Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine
    Takeuchi, H
    Morton, DL
    Elashoff, D
    Hoon, DSB
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (06) : 1032 - 1038
  • [7] Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients
    Helge Taubert
    Matthias Kappler
    Matthias Bache
    Frank Bartel
    Thomas Köhler
    Christine Lautenschläger
    Karen Blümke
    Peter Würl
    Hannelore Schmidt
    Axel Meye
    Steffen Hauptmann
    Oncogene, 2005, 24 : 5258 - 5261
  • [8] Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients
    Taubert, H
    Kappler, M
    Bache, M
    Bartel, F
    Köhler, T
    Lautenschläger, C
    Blümke, K
    Würl, P
    Schmidt, H
    Meye, A
    Hauptmann, S
    ONCOGENE, 2005, 24 (33) : 5258 - 5261
  • [9] High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma
    Du, Xiaolong
    Zhang, Chen
    Yin, Chuanzheng
    Wang, Wenjie
    Yan, Xueke
    Xie, Dawei
    Zheng, Xichuan
    Zheng, Qichang
    Li, Min
    Song, Zifang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Survivin Is Highly Expressed in AML Stem Cells and Predicts Poor Clinical Outcome
    Carter, Bing Z.
    Qiu, Yihua
    Huang, Xielin
    Diao, Lixia
    Zhang, Nianxiang
    Coombes, Kevin R.
    Mak, Duncan H.
    Konopleva, Marina
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Andreeff, Michael
    Kornblau, Steven M.
    BLOOD, 2011, 118 (21) : 108 - 109
12345